I’ve seen guesstimates of IncellDx revenue on boards anywhere from 4 to 14 million, give or take. At 4 million , IncellDx was asking for a price of $350m with the initial payment of 150m . If this is incorrect someone please respond. At 4 million revenue they wanted just under 100 times revenue for a diagnostic type company, not a drug company. That alone is an ridiculous valuation .